Comparison of antimetabolites in the treatment of breast and colon cancer.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000963:Antimetabolites / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008136:Longevity; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*; D012256:Riboflavin / Q000627:therapeutic use
D000963:Antimetabolites; D012256:Riboflavin; D005472:Fluorouracil; D008727:Methotrexate